United States: Anti-abortion politicians have made a renewed attempt to ban utilizing the abortion drug mifepristone, with Missouri, Kansas, and Idaho bringing an amended FDA joint lawsuit.
The lawsuit was filed in a Texas federal court Friday, a little more than four months after the Supreme Court declined to reverse changes to the FDA’s rules surrounding the abortion pill that broadened access – including allowing it to be prescribed and ordered through the mail without an in-person examination.
More about the news
In the suit, the states’ attorneys general are seeking Federal regulators to prohibit the drug’s use after seven weeks of pregnancy instead of 10 and for three in-person doctor’s office visits before people can access it.
Hill reported that the litigation also seeks to overturn the FDA approval of generic variants of the drug.
Pfizer’s mifepristone, plaintiffs claim to be lethal and states sending women with this medication to the emergency rooms.
About Medicated abortions
Medication abortions involve the administration of two medicines, one after the other: mifepristone to stop pregnancy and misoprostol to cause contractions.
It has been classified safe by the FDA, as well as by other organizations such as the Association of American Medical Colleges.
Subsequently, the grounds were revoked by the Supreme Court in 2022 involving Roe v. Wade, and the medication abortions have been realized in the country.
Medication abortions constituted 53 percent of the abortions done in the United States in 2020. The representation of medication abortions increased to 63 percent of all abortions by 2023, as reported by the Guttmacher Institute.
Abortionist, nor is the claim that key federal rules and regulations concerning use and administration “seek to undermine” state abortion laws and state law enforcement, that abortion pills are “flooding” Missouri or Idaho, for instance, as the Hill reported.
Abortion is almost entirely prohibited in both states, with the only exemptions possible in cases when the life of the mother is in peril. The FDA did not respond to a statement about the lawsuit.